Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Clinical Trial ID NCT05213312

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT05213312

Top papers